RE RBG who & what - NIH? EPO?
L Armstrong -
“According to the USADA's 2012 report, he used the hormone Erythropoietin (or EPO) to boost red cell production and oxygen intake. When blood and urine tests to detect EPO became more accurate, he switched to blood transfusions, essentially an older method of reaching the same outcome…
He also used human growth hormone as well as testosterone and cortisone, both steroid hormones that build muscle, control pain, and help athletes recover from injury….
DOPING TECHNOLOGY IS PART OF SILICON VALLEY HISTORY
Victor Conte, on the other hand, was a funk-rock bass player whose wife Audrey Stein ran a holistic health shop near San Francisco before he founded the Bay Area Laboratory Cooperative (BALCO) in Burlingame, California. BALCO was nearly the perfect Silicon Valley startup, a mix of new age ideals and clear-eyed capitalism. Conte's dream beginning in the early 1980s, was to use biometric data, nutritional supplements, and eventually, designer steroids to revolutionize human fitness:
Conte [was] a mercurial eccentric, a driven entrepreneur who built a prosperous nutritional business without any formal scientific or medical background. He did so with unique skills, they said, including a photographic memory that made it possible for Conte to instantly recall complex molecular structures and expertly link them to test results from clients who had been examined weeks, or months, earlier. At the same time, simple details, like routine accounting procedures, could be entirely disregarded, they said.,.
Where is the next Bay Area Laboratory Cooperative?…”
https://www.theverge.com/2013/1/17/3886424/programming-your-body-lance-armstrong-and-doping-technology - 1/7/13
And-
Dr Alison Gould, Scientific Communications Specialist for the Australian Red Cross Blood Service, co-authored this article:
Young blood: magic or medicine?
March 15, 2018
“A company called Alkahest, based on work by Tony Wyss-Coray, a neurobiologist studying Alzheimer’s disease at Stanford University, is spruiking the results of a trial where plasma from young donors (aged 18-30) was transfused into patients with dementia.”
https://theconversation.com/young-blood-magic-or-medicine-88956
And-
NIH study using EPO to reduce blood transfusions in infants: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4418561/#!po=0.555556